文献速递主动脉外科

主动脉弓再次手术:120例患者的早期与中期结局

Aortic arch redo surgery: early and mid-term outcomes in 120 patients.
PubMed 文献 · Eur J Cardiothorac Surg · 2023-01-01

该回顾性研究分析了1996年1月至2022年12月间120例初次近端主动脉手术后行主动脉弓再次手术的患者,主要适应证包括新发动脉瘤、夹层后动脉瘤扩张、人工血管感染和新发夹层。院内死亡率为11.7%,30天死亡率为15.0%,卒中发生11例(9.2%),截瘫1例。动脉瘤病史和术前危重状态是30天死亡的独立预测因素,糖尿病和外周动脉疾病是晚期死亡的独立预测因素。

要点

  • 主动脉弓再次手术院内死亡率11.7%,30天死亡率15.0%,卒中发生率9.2%。
  • 动脉瘤病史(OR 4.5)和术前危重状态(OR 5.9)是30天死亡的独立预测因素。
  • 糖尿病(HR 2.4)和外周动脉疾病(HR 4.7)是晚期死亡的独立预测因素。

核心结论

  • 尽管技术难度大,主动脉弓再次手术可行且可获得可接受的结果。

研究设计与样本

  • 回顾性分析1996年1月至2022年12月间120例初次近端主动脉手术后行主动脉弓再次手术患者的围术期数据及早期和中期结局。

主要发现

  • 再次干预指征包括新发主动脉瘤34例(28.3%)、夹层后动脉瘤扩张36例(30.0%)、主动脉人工血管感染39例(32.5%)和新发主动脉夹层9例,2例因医源性并发症再次手术,31例(25.8%)合并心内膜炎。
  • 院内死亡率和30天死亡率分别为11.7%和15.0%,卒中11例(9.2%),截瘫1例。
  • 动脉瘤病史(OR 4.5;95%CI 1.4-17.3)和术前危重状态(OR 5.9;95%CI 1.5-23.7)是30天死亡的独立预测因素。
  • 总体1年和5年生存率分别为65.8±8.8%和51.2±10.6%,糖尿病(HR 2.4;95%CI 1.0-5.1)和外周动脉疾病(HR 4.7;95%CI 1.1-14.3)是晚期死亡的独立预测因素。
  • 5年再次手术累积发生率为12.6%(95%CI 6.7-20.4%),结缔组织病(亚分布HR 4.5;95%CI 1.6-15.7)和初次与再次手术间隔时间(亚分布HR 1.04;95%CI 1.02-1.06)是再次弓部手术后再次手术的独立预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to analyse the indications, surgical extent and results of treatment, as well as determine the risk factors for adverse outcomes after redo arch surgery. METHODS: Between January 1996 and December 2022, 120 patients underwent aortic arch reoperations after primary proximal aortic surgery. We retrospectively analysed perioperative data, as well as early and mid-term outcomes in these patients. RESULTS: Indications for arch reintervention included new aortic aneurysm in 34 patients (28.3%), expanding post-dissection aneurysm in 36 (30.0%), aortic graft infection in 39 (32.5%) and new aortic dissection in 9 cases. Two patients underwent reoperation due to iatrogenic complications. Thirty-one patients (25.8%) had concomitant endocarditis. In-hospital and 30-day mortality rates were 11.7% and 15.0%, respectively. Stroke was observed in 11 (9.2%) and paraplegia in 1 patient. Prior surgery due to aneurysm [odds ratio 4.5; 95% confidence interval (CI) 1.4-17.3] and critical preoperative state (odds ratio 5.9; 95% CI 1.5-23.7) were independent predictors of 30-day mortality. Overall 1- and 5-year survival was 65.8 ± 8.8% and 51.2 ± 10.6%, respectively. Diabetes mellitus (hazard ratio 2.4; 95% CI 1.0-5.1) and peripheral arterial disease (hazard ratio 4.7; 95% CI 1.1-14.3) were independent predictors of late death. The cumulative incidence of reoperations was 12.6% (95% CI 6.7-20.4%) at 5 years. Accounting for mortality as a competing event, connective tissue disorders (subdistribution hazard ratio 4.5; 95% CI 1.6-15.7) and interval between primary and redo surgery (subdistribution hazard ratio 1.04; 95% CI 1.02-1.06) were independent predictors of reoperations after redo arch surgery. CONCLUSIONS: Despite being technically demanding, aortic arch reoperations are feasible and can be performed with acceptable results.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Dietze Z, Kang J, Madomegov K, et al. Aortic arch redo surgery: early and mid-term outcomes in 120 patients. Eur J Cardiothorac Surg. 2023. PMID: 38109680. doi:10.1093/ejcts/ezad419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。